India Digest: Carlyle may back BDR Pharma; PE funds eye Esskay; Bain in race for Max Healthcare

India Digest: Carlyle may back BDR Pharma; PE funds eye Esskay; Bain in race for Max Healthcare

Visual from BDR Pharma website

Private equity firm Carlyle is in talks to invest $100 million in Mumbai-based drug company BDR Pharma, while private equity biggies are eyeing a minority stake in Jaipur based NBFC Esskay Fincorp Ltd for about $60-70 million. In another development, Bain Capital Private Equity has joined the race to buy a 47 per cent stake in Max Healthcare.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter